Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size
Vivek Jain(Regeneron (United States)), Steven G. Deeks(University of California, San Francisco), Wendy Hartogensis(University of California, San Francisco), Frederick Hecht(University of California, San Francisco), Lorrie Epling(University of California, San Francisco), Peter Bacchetti(University of California, San Francisco), Michael P. Busch(Vitalant), Joseph M. McCune(Gates Foundation), Peter W. Hunt(University of California, San Francisco), Tzong‐Hae Lee(Blood Systems Research Institute), Elizabeth Sinclair(San Francisco General Hospital), Christopher D. Pilcher(University of California, San Francisco), Hiroyu Hatano(San Francisco General Hospital)
Cited by 330
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k